Abstract:Topic: 20. Lymphoma Biology & Translational Research Background: T-cell large granular lymphocytic leukemia (T-LGLL) is a chronic lymphoproliferative disease of mature T cells, characterized by monoclonal T-cell large granular lymphocytosis, often clinically manifest as bone marrow failure and accompany with autoimmune symptoms. Immunosuppressive therapies are effective, but the dominant clone may persist even in responders. The pathogenesis of T-LGLL has not been fully elucidated. In this study, single-cell RNA sequencing and V(D)J profiling were performed to discern clonotypes and gene expression patterns of T lymphocytes from T-LGLL patients. Aims: To identify the biomarkers of leukemic large granular lymphocytes (LGLs) and explore novel agent for treating T-LGLL. Methods: Peripheral blood samples were collected from five T-LGLL patients, three T-cell clones of uncertain significance (T-CUS) patients and three healthy donors. single-cell RNA library was performed on the 10x Genomics Chromium Single Cell V(D)J and 5’ Gene Expression platform, and sequencing obtained on the Illumina Platform. Barcode assignment, alignment, unique molecular index counting and T cell receptor sequence assembly were performed using Cell Ranger 6.1.0. Immune cells were clustered and annotated, then transcriptome characteristics of each group of cells were analyzed, T cell receptor (TCR) clonetype and clonesize were identified. Results: By analyzing the characteristics of transcriptome and immune library of CD8 T cells from all samples, terminal effector T cells were divided into three clusters (which named CD8 TE1, CD8 TE2 and CD8 TE3). Almost all of TE3 cluster, which characterized by decreased clonetype diversity, were from T-LGLL patients. To identify whether TE3 cluster was pathogenic, we mapped the transcriptome on previous sequencing of T-LGLLs (Nat commun(2022)13:1981 and Nat commun (2022)13:1982) and verified TE3 cluster was the leukemic subpopulation. Compared with non-leukemic effector T cells, this leukemic subpopulation demonstrated higher toxicity and increased proliferative function. Interestingly, upregulated exhausted genes were also observed in this cluster. Furthermore, cell killing, TCR activation, interferon γ signaling pathway and cytokine production were upregulated in leukemic cluster. Remarkablely, the leukemic effector T cells demonstrated a lower level of killer cell lectinlike receptor G1 (KLRG1). We also verified the significantly decreased expression of surface KLRG1 on CD3+CD8+CD57+ cells in other five T-LGLL patients. Moreover, up-regulated PI3K-AKT pathway was observed in this KLRG1- leukemic subpopulation. Proliferation and cytotoxicity of leukemic lymphocytes from patients were significantly decreased by PI3K inhibitor. Summary/Conclusion: Large granular lymphocytes is a typical KLRG1- clonal T effector cluster, characterized by increased cytotoxicity and exhaustion. PI3K inhibitor, which could restrain proliferation and effector function of leukemic lymphocytes, is a promising agent for T-LGLL. Keywords: LGL

Key candidate genes and pathways in T lymphoblastic leukemia/lymphoma identified by bioinformatics and serological analyses

Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases

Bioinformatics and Raman spectroscopy-based identification of key pathways and genes enabling differentiation between acute myeloid leukemia and T cell acute lymphoblastic leukemia

Bioinformatics Analysis Of Gene Expression Profiles In Chronic Lymphocytic Leukemia

Overlapped Differentially Expressed Genes Between Acute Lymphoblastic Leukemia and Chronic Lymphocytic Leukemia Revealed Potential Key Genes and Pathways Involved in Leukemia

Genomic signatures and prognosis of advanced stage Chinese pediatric T cell lymphoblastic lymphoma by whole exome sequencing

Integrated genomic analyses identify high-risk factors and actionable targets in T-cell acute lymphoblastic leukemia

Identification of Fusion Genes and Characterization of Transcriptome Features in T-cell Acute Lymphoblastic Leukemia.

Ectopic Expression of a Combination of 5 Genes Detects High Risk Forms of T-cell Acute Lymphoblastic Leukemia

P1242: A TRUELY LEUKEMIC SUBPOPULATION IDENTIFIED BY SINGLE CELL SEQUENCING IN T LARGE GRANULAR LYMPHOCYTIC LEUKEMIA

Ectopic Expression of a Combination of 5 Genes Detects High Risk Forms of Adult T-cell Acute Lymphoblastic Leukemia

Regulatory Network Analysis Reveals the Oncogenesis Roles of Feed-Forward Loops and Therapeutic Target in T-cell Acute Lymphoblastic Leukemia.

Identification of Novel Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia

Bioinformatics Analysis of Potential Key Genes and Pathways in Pediatric Patients with Langerhans Cell Histiocytosis

Clinical Significance of Complement and Coagulation Cascades Genes for Patients With Acute Lymphoblastic Leukemia

The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

High-Throughput Sequencing Revealing BCR and TCR Repertoires as Potential Prognostic Biomarkers for Pediatric Patients with B-ALL

Digital Gene Expression Profiling Analysis of Childhood Acute Lymphoblastic Leukemia.

Identification of Early Recurrence Factors in Childhood and Adolescent B-Cell Acute Lymphoblastic Leukemia Based on Integrated Bioinformatics Analysis

Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children

Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia